WEBSITE DISCLAIMER

Before downloading, printing or viewing the Prospectus, please carefully read this information. By accessing the Prospectus (by clicking on the link below) you agree to and acknowledge that you have read and accept these terms and conditions of access. The information on this page is not part of the Prospectus. If you do not understand it, you
should consult your professional adviser without delay.

Important Notice

Nanollose Limited ACN 601 676 377 (Company) has lodged a prospectus dated 13 January 2025] (Prospectus) with the Australian Securities and Investments Commission (ASIC) in respect of the following offers:

  1. (a) a non-renounceable pro rata entitlement issue of one fully paid ordinary share in the capital of the company (Share) for every three Shares held by eligible shareholders at an issue price of $0.016 per Share (together with one free attaching option (New Option) for every five Shares applied for and issued) to raise up to approximately $1,050,701 (Entitlement Offer);
  2. (b) up to 8,400,000 New Options to the participants of the Company’s placement announced 13 December 2024 (Placement Offer);
  3. (c) an offer of up to 85,668,789 New Options to Dutch Ink (2010) Pty Ltd (or their nominees) (Investor Offer);
  4. (d) the offer of 25,000,000 Shares together with one New Option for every five Shares applied for and issued to Company directors’ Wayne Best and Winton Willesee (or their nominees) (Director Offer);
  5. (e) 8,000,000 quoted NC6OB options (Quoted Options) to Peak Asset Management (or their nominees) (Adviser Offer),

(together, the Offers).

The Company has specified a target market (Target Market) for investors under the Offers, which is set out in the target market determination available at www.nanollose.com (TMD). The Prospectus can only be accessed by investors in the TMD.

The Prospectus and TMD are important documents which should be read in their entirety. If, after reading the Prospectus you have questions about the Offers, TMD or any other matter, please contact your professional advisers without delay.

Neither ASIC nor ASX Limited, nor any of their respective officers, take any responsibility for the contents of the Prospectus or the merits of the investment to which the Prospectus relates.

The electronic copy of the Prospectus available on this website does not constitute an offer of, or an invitation to subscribe for, any securities. You may print out a hard copy of the Prospectus from this website or copy the electronic Prospectus on this website into an electronic file for your personal use only. You must not alter the contents of this electronic file in any way.

Alternatively, you may obtain a hard copy of the Prospectus free of charge by contacting the Company by phone on +61 8 9389 3120 during office hours or by emailing the Company at info@nanollose.com.au.

To the extent permitted by law, the Company is not liable for any loss incurred from accessing or downloading the Prospectus from this website, including, but not limited to, data corruption or download.

Applications

  • Entitlement Offer: Anyone who wants to take up their entitlement under the Entitlement Offer will need to carefully consider the TMD and Prospectus and complete the personalised Entitlement and Acceptance Form attached to or accompanied by the Prospectus or pay the applications monies in accordance with the details set out in the Prospectus and acceptance form.

  • Placement Offer: The Placement Offer is only being extended to participants of the Company’s placement announced 13 December 2024 (the Placement Participants). Applications for New Options under the Placement Offer must only be made by the Placement Participants using the application form to be provided by the Company and attached to or accompanying the Prospectus. An application form and instructions on how to apply for New Options under the Placement Offer will only be provided to the Placement Participants in accordance with the terms of the Prospectus.

  • Investor Offer: The Investor Offer is only being extended to Dutch Ink (2010) Pty Ltd (or their nominees). Applications for New Options under the Investor Offer must only be made by Dutch Ink (2010) Pty Ltd (or their nominees) using the application form to be provided by the Company and attached to or accompanying the Prospectus. An application form and instructions on how to apply for New Options under the Investor Offer will only be provided to Dutch Ink (2010) Pty Ltd (or their nominees) in accordance with the terms of the Prospectus.

  • Director Offer: The Director Offer is only being extended to Wayne Best and Winton Willesee (the Participating Directors) (or their nominees). Applications for Shares and New Options under the Director Offer must only be made by the Participating Directors (or their nominees) using the application form to be provided by the Company and attached to or accompanying the Prospectus. An application form and instructions on how to apply for

    Shares and New Options under the Director Offer will only be provided to the Participating Directors (or their nominees) in accordance with the terms of the Prospectus.

  • Advisor Offer: The Advisor Offer is only being extended to Peak Asset Management (or their nominees). Applications for Quoted Options under the Advisor Offer must only be made by Peak Asset Management (or their nominees) using the application form to be provided by the Company and attached to or accompanying the Prospectus. An application form and instructions on how to apply for Quoted Options under the Advisor Offer will only be provided to Peak Asset Management (or their nominees) in accordance with the terms of the Prospectus.

The Corporations Act 2001 (Cth) prohibits any person from passing onto another person an application form unless it is attached to or accompanied by a complete and unaltered version of the Prospectus.

The Company reserves the right not to accept acceptance form or payment of application monies from a person if it has reason to believe that when that person was given access to the electronic acceptance form, it was not provided together with the electronic Prospectus and any relevant supplementary or replacement prospectus or any of those documents were incomplete or altered.

If an acceptance form is not completed correctly, or if the accompanying payment is the wrong amount, the Company may, in its discretion, still treat the acceptance form to be valid. The Company’s decision to treat an acceptance as valid, and how to construe, amend or complete the acceptance form, will be final.

No Advice

Nothing contained on this website or in the Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus does not take into account your financial or investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of the Company, the securities being offered for and the terms of the offering, including the merits and risks involved. You should consult your professional advisers for investment, legal, business, tax or other advice.

Persons to whom Offers are available

For legal reasons, the electronic version of the Prospectus accessible through this website is available to persons accessing this website from within Australia, New Zealand, Hong Kong and Germany only (Permitted Jurisdictions). If you are accessing this website from anywhere outside a Permitted Jurisdiction, please do not download the electronic version of the Prospectus.

The Prospectus does not constitute an offer, or invitation to apply for, of securities in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus or to make the offer or invitation. It is the responsibility of any applicant outside a Permitted Jurisdiction to ensure compliance with all laws of any country relevant to their applications, and any such applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be allotted any securities.

It is not practicable for the Company to comply generally with the securities laws of overseas jurisdictions having regard to the number of overseas shareholders, the number and value of securities those shareholders would be offered and the cost of complying with regulatory requirements in each relevant jurisdiction. Accordingly, the offer pursuant to the Prospectus is only being extended and securities will only be issued to shareholders with a registered address in a Permitted Jurisdiction.

Acknowledgement

By clicking “I Accept” below, you acknowledge and agree that:

  • You have read and understood the TMD and that you either fall within the Target Marketor, if you do not fall within the Target Market, you are accessing the Prospectus for information purposes only and that you will not make an application under the Offers.

  • You have read and understood the above terms and conditions to access the electronic version of the Prospectus;

  • You are a resident in a Permitted Jurisdiction and you are requesting a copy of the Prospectus from within a Permitted Jurisdiction;

    OR

    If you are not a resident in a Permitted Jurisdiction, you have consulted your professional adviser as to whether any governmental or other consents are required or whether any other formalities need to be considered and followed before accessing the Prospectus; and

  • You will not pass onto any other person the Acceptance Form unless it is attached to or accompanied by the complete and unaltered electronic version of the Prospectus and the TMD.